Overview
Description
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan
Financials
Key metrics
| Market capitalisation, EUR | 6,912 m |
| EPS, EUR | 0.79 |
| P/B ratio | 1.4 |
| P/E ratio | 19.2 |
| Dividend yield | 3.14% |
Income statement (2024)
| Revenue, EUR | 2,979 m |
| Net income, EUR | 306 m |
| Profit margin | 10.28% |
What ETF is Ono Pharmaceutical Co., Ltd. in?
There are 24 ETFs which contain Ono Pharmaceutical Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ono Pharmaceutical Co., Ltd. is the iShares MSCI Japan Small Cap UCITS ETF (Dist).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
